Trypanothione metabolism and rational approaches to drug design.
Fairlamb
A H
AH
Department of Medical Parasitology, London School of Hygiene and Tropical Medicine, U.K.
D000818:Animals; D015195:Drug Design; D005978:Glutathione / Q000031:analogs & derivatives* / Q000378:metabolism; D009247:NADH, NADPH Oxidoreductases / Q000378:metabolism; D013095:Spermidine / Q000031:analogs & derivatives* / Q000378:metabolism; D014344:Trypanocidal Agents / Q000138:chemical synthesis* / Q000494:pharmacology; D014345:Trypanosoma / Q000187:drug effects / Q000378:metabolism*
D014344:Trypanocidal Agents; C044809:trypanothione; D009247:NADH, NADPH Oxidoreductases; C049608:trypanothione reductase; D005978:Glutathione; D013095:Spermidine